Clinical Trials
38 trialsPIKALO-1
Eli Lilly and Company
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Morpheus-panBC
Hoffmann-La Roche
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Genentech, Inc.
METALLICA
MedSIR
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Canadian Cancer Trials Group
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Columbia University
METBC
Woman's
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Columbia University
METRICS
Health Clinics Limited
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
Beni-Suef University
Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
Tanta University
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Ozmosis Research Inc.
The Effect of Metformin on Breast Cancer Patients
Beni-Suef University
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.
Mansoura University
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
University of California, San Diego
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
MBC1
N.N. Petrov National Medical Research Center of Oncology
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
Exercise and Metformin in Colorectal and Breast Cancer Survivors
Dana-Farber Cancer Institute
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Indiana University
Study of Erlotinib and Metformin in Triple Negative Breast Cancer
Columbia University
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Metformin and Simvastatin in Addition to Fulvestrant
National University Hospital, Singapore
The Impact of Obesity and Obesity Treatments on Breast Cancer
M.D. Anderson Cancer Center
MYME
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients
Seoul National University Hospital
Effect of Metformin on Breast Cancer Metabolism
Oxford University Hospitals NHS Trust
Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer
Fondazione Michelangelo
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
National Cancer Institute (NCI)
Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Mount Sinai Hospital, Canada